Tolfenamic acid decreases c-Met expression through Sp proteins degradation and inhibits lung cancer cells growth and tumor formation in orthotopic mice

By Colon Jimmie   Basha Md.   Madero-Visbal Rafael   Konduri Santhi   Baker Cheryl   Herrera Luis   Safe Stephen   Sheikh-Hamad David   Abudayyeh Ala   Alvarado Beatrice   Abdelrahim Maen  

Investigational New Drugs, Vol. 29, Iss. 1, 2011-02 ,pp. : 41-51

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant Chemotherapy for Lung Cancer: Cisplatin Doublets Only?

By Morgensztern Daniel   Govindan Ramaswamy  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 3, 2008-03 ,pp. : 277-284

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Synergistic Effect of the Combination of Novel Suberoylanilide Hydroxamic Acid Derivatives with Cisplatin on Anti-proliferation of Human Cancer Cells

By  

Medicinal Chemistry, Vol. 12, Iss. 8, 2016-12 ,pp. : 767-774

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of cisplatin and cis-platinum (II) phosphonate complex on murine mast cells

By Brzezinska-Blaszczyk E.   Mincikiewicz M.   Ochocki J.  

European Journal of Pharmacology, Vol. 298, Iss. 2, 1996-03 ,pp. : 155-158

Elsevier

Access to resources Recommend Favorite

Fluorouracil + folinic acid + cisplatin active in gastric cancer

By  

Inpharma, Vol. 1, Iss. 1594, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite